Does the media favor ATRC or SSII?

In the previous week, AtriCure had 4 more articles in the media than SS Innovations International. MarketBeat recorded 15 mentions for AtriCure and 11 mentions for SS Innovations International. AtriCure's average media sentiment score of 0.88 beat SS Innovations International's score of 0.78 indicating that AtriCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SS Innovations International 4 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SSII or BFLY?

In the previous week, Butterfly Network had 3 more articles in the media than SS Innovations International. MarketBeat recorded 14 mentions for Butterfly Network and 11 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 0.78 beat Butterfly Network's score of 0.62 indicating that SS Innovations International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 4 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Butterfly Network 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SSII or ESTA?

In the previous week, SS Innovations International had 5 more articles in the media than Establishment Labs. MarketBeat recorded 11 mentions for SS Innovations International and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.57 beat SS Innovations International's score of 0.78 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 4 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer NVCR or SSII?

In the previous week, SS Innovations International had 7 more articles in the media than NovoCure. MarketBeat recorded 11 mentions for SS Innovations International and 4 mentions for NovoCure. SS Innovations International's average media sentiment score of 0.78 beat NovoCure's score of 0.65 indicating that SS Innovations International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SS Innovations International 4 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SSII or LMAT?

In the previous week, SS Innovations International had 9 more articles in the media than LeMaitre Vascular. MarketBeat recorded 11 mentions for SS Innovations International and 2 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.82 beat SS Innovations International's score of 0.78 indicating that LeMaitre Vascular is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 4 Very Positive mention(s) 4 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

SS Innovations International (SSII) Competitors

$3.30 +0.08 (+2.48%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$3.32 +0.02 (+0.45%)

As of 04:01 AM Eastern

Compare

SSII vs. ATRC, BFLY, ESTA, NVCR, and LMAT

Should you buy SS Innovations International stock or one of its competitors? SS Innovations International's main competitors and comparable companies include AtriCure (ATRC), Butterfly Network (BFLY), Establishment Labs (ESTA), NovoCure (NVCR), and LeMaitre Vascular (LMAT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SS Innovations International compare to AtriCure?

AtriCure (NASDAQ:ATRC) and SS Innovations International (NASDAQ:SSII) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

In the previous week, AtriCure had 4 more articles in the media than SS Innovations International. MarketBeat recorded 15 mentions for AtriCure and 11 mentions for SS Innovations International. AtriCure's average media sentiment score of 0.88 beat SS Innovations International's score of 0.78 indicating that AtriCure is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	10 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	4 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.1% of AtriCure shares are held by institutional investors. 4.0% of AtriCure shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

AtriCure has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	5.04	-$11.45M	$0.21	252.19
SS Innovations International	$42.49M	15.56	-$12.13M	-$0.06	N/A

AtriCure presently has a consensus price target of $52.00, indicating a potential downside of 1.81%. SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 112.12%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

AtriCure has a net margin of 1.85% compared to SS Innovations International's net margin of -23.73%. AtriCure's return on equity of 2.34% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	1.85%	2.34%	1.77%
SS Innovations International	-23.73%	-26.77%	-15.01%

AtriCure has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.94, suggesting that its stock price is 294% less volatile than the broader market.

Summary

AtriCure beats SS Innovations International on 15 of the 17 factors compared between the two stocks.

How does SS Innovations International compare to Butterfly Network?

SS Innovations International (NASDAQ:SSII) and Butterfly Network (NYSE:BFLY) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 112.12%. Butterfly Network has a consensus price target of $5.56, indicating a potential downside of 21.74%. Given SS Innovations International's higher possible upside, equities analysts clearly believe SS Innovations International is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

SS Innovations International has a net margin of -23.73% compared to Butterfly Network's net margin of -66.74%. SS Innovations International's return on equity of -26.77% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
Butterfly Network	-66.74%	-33.99%	-22.96%

37.9% of Butterfly Network shares are owned by institutional investors. 22.0% of Butterfly Network shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SS Innovations International has higher earnings, but lower revenue than Butterfly Network. SS Innovations International is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	15.56	-$12.13M	-$0.06	N/A
Butterfly Network	$97.61M	19.39	-$77.06M	-$0.29	N/A

In the previous week, Butterfly Network had 3 more articles in the media than SS Innovations International. MarketBeat recorded 14 mentions for Butterfly Network and 11 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 0.78 beat Butterfly Network's score of 0.62 indicating that SS Innovations International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	4 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Butterfly Network	8 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SS Innovations International has a beta of -1.94, indicating that its share price is 294% less volatile than the broader market. Comparatively, Butterfly Network has a beta of 2.08, indicating that its share price is 108% more volatile than the broader market.

Summary

Butterfly Network beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to Establishment Labs?

SS Innovations International (NASDAQ:SSII) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

SS Innovations International has higher earnings, but lower revenue than Establishment Labs. SS Innovations International is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	15.56	-$12.13M	-$0.06	N/A
Establishment Labs	$211.08M	10.08	-$51.06M	-$1.31	N/A

SS Innovations International has a beta of -1.94, indicating that its stock price is 294% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market.

Establishment Labs has a net margin of -15.82% compared to SS Innovations International's net margin of -23.73%. SS Innovations International's return on equity of -26.77% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
Establishment Labs	-15.82%	-196.69%	-10.73%

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 112.12%. Establishment Labs has a consensus price target of $100.25, indicating a potential upside of 40.43%. Given SS Innovations International's higher possible upside, research analysts plainly believe SS Innovations International is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

In the previous week, SS Innovations International had 5 more articles in the media than Establishment Labs. MarketBeat recorded 11 mentions for SS Innovations International and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.57 beat SS Innovations International's score of 0.78 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	4 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

72.9% of Establishment Labs shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Establishment Labs beats SS Innovations International on 10 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to NovoCure?

NovoCure (NASDAQ:NVCR) and SS Innovations International (NASDAQ:SSII) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

NovoCure presently has a consensus price target of $21.20, indicating a potential upside of 38.11%. SS Innovations International has a consensus price target of $7.00, indicating a potential upside of 112.12%. Given SS Innovations International's higher probable upside, analysts plainly believe SS Innovations International is more favorable than NovoCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovoCure	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NovoCure has a net margin of -21.25% compared to SS Innovations International's net margin of -23.73%. SS Innovations International's return on equity of -26.77% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NovoCure	-21.25%	-44.00%	-15.85%
SS Innovations International	-23.73%	-26.77%	-15.01%

In the previous week, SS Innovations International had 7 more articles in the media than NovoCure. MarketBeat recorded 11 mentions for SS Innovations International and 4 mentions for NovoCure. SS Innovations International's average media sentiment score of 0.78 beat NovoCure's score of 0.65 indicating that SS Innovations International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NovoCure	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
SS Innovations International	4 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SS Innovations International has lower revenue, but higher earnings than NovoCure. SS Innovations International is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NovoCure	$655.35M	2.73	-$136.23M	-$1.30	N/A
SS Innovations International	$42.49M	15.56	-$12.13M	-$0.06	N/A

NovoCure has a beta of 1.01, indicating that its stock price is 1% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.94, indicating that its stock price is 294% less volatile than the broader market.

84.6% of NovoCure shares are owned by institutional investors. 6.6% of NovoCure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

NovoCure and SS Innovations International tied by winning 8 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to LeMaitre Vascular?

SS Innovations International (NASDAQ:SSII) and LeMaitre Vascular (NASDAQ:LMAT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

LeMaitre Vascular has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	15.56	-$12.13M	-$0.06	N/A
LeMaitre Vascular	$249.60M	7.22	$57.73M	$2.85	27.65

SS Innovations International has a beta of -1.94, indicating that its share price is 294% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

SS Innovations International presently has a consensus price target of $7.00, suggesting a potential upside of 112.12%. LeMaitre Vascular has a consensus price target of $110.60, suggesting a potential upside of 40.36%. Given SS Innovations International's higher probable upside, research analysts clearly believe SS Innovations International is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

84.6% of LeMaitre Vascular shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

LeMaitre Vascular has a net margin of 25.02% compared to SS Innovations International's net margin of -23.73%. LeMaitre Vascular's return on equity of 15.63% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
LeMaitre Vascular	25.02%	15.63%	10.06%

In the previous week, SS Innovations International had 9 more articles in the media than LeMaitre Vascular. MarketBeat recorded 11 mentions for SS Innovations International and 2 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.82 beat SS Innovations International's score of 0.78 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	4 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

LeMaitre Vascular beats SS Innovations International on 13 of the 16 factors compared between the two stocks.

Get SS Innovations International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSII vs. The Competition

Export

Metric	SS Innovations International	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$645.24M	$5.58B	$7.21B	$12.81B
Dividend Yield	N/A	1.78%	2.56%	10.55%
P/E Ratio	-55.00	24.44	272.82	25.11
Price / Sales	15.56	72.62	618.93	90.53
Price / Cash	N/A	32.69	77.33	51.83
Price / Book	16.50	5.89	10.42	6.18
Net Income	-$12.13M	$150.94M	$3.49B	$358.18M
7 Day Performance	-3.23%	-3.02%	-3.14%	-2.49%
1 Month Performance	-8.59%	-3.87%	0.04%	-2.72%
1 Year Performance	-47.62%	5.62%	17.33%	7.74%

SS Innovations International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSII SS Innovations International	1.5666 of 5 stars	$3.30 +2.5%	$7.00 +112.1%	-48.1%	$645.24M	$42.49M	N/A	4	News Coverage High Trading Volume
ATRC AtriCure	2.6189 of 5 stars	$48.54 -1.5%	$49.89 +2.8%	+50.7%	$2.51B	$534.53M	231.15	1,300	Insider Trade
BFLY Butterfly Network	1.1182 of 5 stars	$8.48 -2.8%	$5.56 -34.4%	+378.7%	$2.32B	$97.61M	N/A	460	Insider Trade Gap Down
ESTA Establishment Labs	3.1521 of 5 stars	$70.64 -1.6%	$100.25 +41.9%	+88.2%	$2.14B	$211.08M	N/A	1,004	Gap Down
NVCR NovoCure	2.4118 of 5 stars	$17.82 -0.9%	$21.20 +19.0%	+25.7%	$2.09B	$655.35M	N/A	1,605	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSII) was last updated on 9/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SS Innovations International (SSII) Competitors

SSII vs. ATRC, BFLY, ESTA, NVCR, and LMAT

How does SS Innovations International compare to AtriCure?

Summary

How does SS Innovations International compare to Butterfly Network?

Summary

How does SS Innovations International compare to Establishment Labs?

Summary

How does SS Innovations International compare to NovoCure?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SS Innovations International (SSII) Competitors

SSII vs. ATRC, BFLY, ESTA, NVCR, and LMAT

How does SS Innovations International compare to AtriCure?

Does the media favor ATRC or SSII?

Do institutionals & insiders have more ownership in ATRC or SSII?

Which has stronger earnings & valuation, ATRC or SSII?

Do analysts prefer ATRC or SSII?

Is ATRC or SSII more profitable?

Which has more volatility and risk, ATRC or SSII?

Summary

How does SS Innovations International compare to Butterfly Network?

Do analysts prefer SSII or BFLY?

Is SSII or BFLY more profitable?

Do institutionals and insiders believe in SSII or BFLY?

Which has preferable valuation & earnings, SSII or BFLY?

Does the media prefer SSII or BFLY?

Which has more risk & volatility, SSII or BFLY?

Summary

How does SS Innovations International compare to Establishment Labs?

Which has higher valuation and earnings, SSII or ESTA?

Which has more volatility and risk, SSII or ESTA?

Is SSII or ESTA more profitable?

Do analysts rate SSII or ESTA?

Does the media prefer SSII or ESTA?

Do insiders & institutionals believe in SSII or ESTA?

Summary

How does SS Innovations International compare to NovoCure?

Do analysts recommend NVCR or SSII?

Is NVCR or SSII more profitable?

Does the media prefer NVCR or SSII?

Which has stronger valuation & earnings, NVCR or SSII?

Which has more risk and volatility, NVCR or SSII?

Do insiders & institutionals have more ownership in NVCR or SSII?

Summary

How does SS Innovations International compare to LeMaitre Vascular?

Which has better earnings and valuation, SSII or LMAT?

Which has more risk and volatility, SSII or LMAT?

Do analysts rate SSII or LMAT?

Do institutionals & insiders believe in SSII or LMAT?

Is SSII or LMAT more profitable?

Does the media prefer SSII or LMAT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSII vs. The Competition

SS Innovations International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools